Evidence mapPaperPMID 38033089Full record

GuidelineCirculation2024

2023 ACC/AHA/ACCP/HRS Guideline for the Diagnosis and Management of Atrial Fibrillation: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines.

José A Joglar, Mina K Chung, Anastasia L Armbruster, Emelia J Benjamin, Janice Y Chyou, Edmond M Cronin, Anita Deswal, Lee L Eckhardt, Zachary D Goldberger, Rakesh Gopinathannair and 25 more

Erratum issued 7 registry-linked trialsOpen access · hybridAbstract readPractice Guideline
In one paragraph

Guideline in Circulation, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. It is linked to 7 registered trials, which are not on this map. Cited by 1,401 papers, 12 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
1,401citing papers in PubMed, 12 pooled it
456.0field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT07030335 nanot yet recruitingnot on this mapstarted 2025, after this paper: background citation

The Effect Of A Mobıle Educatıon Program and Telephone Follow-Up On Knowledge Level, Symptom Management And Qualıty Of Lıfe In Patıents Wıth Atrıal Fıbrıllatıon

TypeinterventionalSponsorAkdeniz UniversityRan2025 to 2025Enrolled70ConditionsAtrial Fibrillation (AF)ArmsMobile-Atrial Fibrillation Training Program, Routine Outpatient Clinic Care
NCT07138183 naactive not recruitingnot on this mapstarted 2025, after this paper: background citation

The Impact of Nurse Practitioner-Led Multidisciplinary Team Intervention on the Implementation of Guideline-Directed Medical Therapy and Clinical Outcomes in Adults With Multimorbidity: A Randomized Controlled Trial

TypeinterventionalSponsorNational Taiwan University HospitalRan2025 to 2026Enrolled178ConditionsMultimorbidityArmsNP-led MDT, Usual Care
NCT07171242 recruitingnot on this map

Shanghai Prospective Registry Study of Ischemic Stroke

TypeobservationalSponsorQiang DongRan2024 to 2029Enrolled15,000ConditionsIschemic Stroke
NCT07360899 narecruitingnot on this mapstarted 2025, after this paper: background citation

Left Atrial Appendage Closure During Cardiac Surgery in Atrial Fibrillation Patients With Seralene

TypeinterventionalSponsorInstitute of Cardiovascular Diseases, VojvodinaRan2025 to 2026Enrolled200ConditionsATRIAL APPENDAGE CLOSURE for ATRIAL FIBRILLATION, Atrial Fibrillation (AF), Mitral Valve Surgery, Stroke (in Patients With Atrial Fibrillation)ArmsLAA closure using the AtriLASH
NCT07582523 naenrolling by invitationnot on this mapstarted 2026, after this paper: background citation

Out-of-office Monitoring for Rhythms Of Normal Versus Atrial Fibrillation

TypeinterventionalSponsorUniversity of California, San FranciscoRan2026 to 2029Enrolled1,910ConditionsAtrial Fibrillation (AF), Hypertension (HTN), High Blood PressureArmsBlood Pressure Monitor Without AFib Detection, Blood Pressure Monitor With AFib Detection
NCT07708818 not yet recruitingnot on this mapstarted 2027, after this paper: background citation

DYNAMIC-AF HF Study: An AI-ECG-Based Approach for Dynamic Assessment of Heart Failure Risk and Myocardial Recovery Following Atrial Fibrillation Ablation

TypeobservationalSponsorEwha Womans University Mokdong HospitalRan2027 to 2029Enrolled1,000ConditionsAtrial Fibrillation (AF), Heart Failure With Mildly Reduced Ejection Fraction (HFmrEF)
NCT07755072 nanot yet recruitingnot on this mapstarted 2026, after this paper: background citation

The Effect of Ligament of Marshall Excision During Minimally Invasive Cardiac Surgery-Coronary Artery Bypass Grafting (MICS-CABG) on the Prevention of Postoperative New-Onset Atrial Fibrillation: A Multicenter, Prospective, Randomized, Triple-Blinded Study

TypeinterventionalSponsorPeking University Third HospitalRan2026 to 2028Enrolled628ConditionsPostoperative Atrial FibrillationArmsMICS-CABG combined with excision of the Ligament of Marshall
3 · Its place in the literature

Who cites it

1,401 citing papers in PubMed, 12 syntheses or guidelines pooled it, 2,079 citations in OpenAlex.

  1. Pooled it
  2. Clinical outcomes of continuing vs. discontinuing oral anticoagulation after atrial fibrillation ablation: an updated systematic review and meta-analysis of observational studies and randomized controlled trials.Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology · 2026
    Pooled it
  3. Long-term efficacy and safety of left atrial appendage closure vs. oral anticoagulation in atrial fibrillation: a meta-analysis of randomized controlled trials.Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology · 2026
    Pooled it
  4. Comparative evaluation of left atrial appendage occlusion and oral anticoagulation: a Bayesian meta-analysis of randomized controlled trials.Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology · 2026
    Pooled it
  5. Guideline
  6. Pooled it
  7. Comparing GLP-1 agonists versus other weight loss interventions on risk of atrial fibrillation recurrence after catheter ablation: a meta-analysis.Journal of interventional cardiac electrophysiology : an international journal of arrhythmias and pacing · 2026
    Pooled it
  8. Pooled it
  9. Pooled it
  10. Pooled it
  11. Pooled it
  12. Pooled it
  13. Trial
  14. Trial
  15. Comparison of the effectiveness and safety of dronedarone and amiodarone for preventing recurrence after catheter ablation of atrial fibrillation: an open-label randomized controlled trial.Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology · 2026
    Trial
  16. Trial
  17. Trial
  18. Article
  19. Clinical subtypes and prognosis of new-onset atrial fibrillation in critically ill patients.International journal of cardiology. Cardiovascular risk and prevention · 2026
    Article
  20. Understanding the Diseased Atria.Physiology (Bethesda, Md.) · 2026
    Review

1,341 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

35 authors at 1 institution in 1 country.

José A Joglar
Mina K Chung
Anastasia L ArmbrusterACC/AHA Joint Committee on Clinical Practice Guidelines liaison.
Emelia J Benjamin
Janice Y Chyou
Edmond M Cronin
Anita DeswalACC/AHA Joint Committee on Clinical Practice Guidelines liaison.
Lee L Eckhardt
Zachary D Goldberger
Rakesh Gopinathannair
Bulent Gorenek
Paul L HessACC/AHA Joint Committee on Performance Measures liaison.
Mark Hlatky
Gail HoganLay stakeholder representative.
Chinwe Ibeh
Julia H Indik
Kazuhiko KidoAmerican College of Clinical Pharmacy representative.
Fred Kusumoto
Mark S Link
Kathleen T LintaLay stakeholder representative.
Gregory M Marcus
Patrick M McCarthy
Nimesh Patel
Kristen K Patton
Marco V Perez
Jonathan P Piccini
Andrea M RussoHeart Rhythm Society representative.
Prashanthan Sanders
Megan M Streur
Kevin L Thomas
Sabrina TimesJoint ACC/AHA staff representative.
James E Tisdale
Anne Marie ValenteACC/AHA Joint Committee on Clinical Data Standards liaison.
David R Van Wagoner
Peer Review Committee Members
Heart Rhythm Society · US

Funding

Project 3 Genes to Omics-Informed Drugs: Drug Repositioning and Testing to Prevent AF ProgressionsP01HL158502 · CLEVELAND CLINIC LERNER COM-CWRU · 2025 to 2025
$2.8M
Deep Mutational Scanning and Functional Analysis of Repolarization DeterminantsR01HL163987 · UNIVERSITY OF WISCONSIN-MADISON · 2025 to 2025
$389k
BLRD VA IK6 BX006185NHLBI NIH HHS P01 HL158502NHLBI NIH HHS R01 HL158071
6 · The paper itself

Abstract

aimThe "2023 ACC/AHA/ACCP/HRS Guideline for the Diagnosis and Management of Atrial Fibrillation" provides recommendations to guide clinicians in the treatment of patients with atrial fibrillation.

methodsA comprehensive literature search was conducted from May 12, 2022, to November 3, 2022, encompassing studies, reviews, and other evidence conducted on human subjects that were published in English from PubMed, EMBASE, the Cochrane Library, the Agency for Healthcare Research and Quality, and other selected databases relevant to this guideline. Additional relevant studies, published through November 2022, during the guideline writing process, were also considered by the writing committee and added to the evidence tables, where appropriate. STRUCTURE: Atrial fibrillation is the most sustained common arrhythmia, and its incidence and prevalence are increasing in the United States and globally. Recommendations from the "2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation" and the "2019 AHA/ACC/HRS Focused Update of the 2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation" have been updated with new evidence to guide clinicians. In addition, new recommendations addressing atrial fibrillation and thromboembolic risk assessment, anticoagulation, left atrial appendage occlusion, atrial fibrillation catheter or surgical ablation, and risk factor modification and atrial fibrillation prevention have been developed.

Indexed as

Atrial FibrillationCardiologyThromboembolismAmerican Heart AssociationHumansRisk FactorsUnited Statesacute coronary syndromeAHA Scientific Statementsalcoholanticoagulantsanticoagulation agentsantiplatelet agentsapixabanatrial fibrillationatrial fluttercardioversioncatheter ablationcoronary artery diseasecoronary heart diseasedabigatranedoxabanexerciseheart failurehypertensionidarucizumableft atrial appendage occlusionmyocardial infarctionobesitypercutaneous coronary interventionpulmonary vein isolationrisk factorsrivaroxabansleep apneastentsstrokesurgical ablationthromboembolismwarfarin

Identifiers

PMID38033089
PMCPMC11095842
OpenAlexW4389166035

What Socratic holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

and 1 more above

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.